Trials / Terminated
TerminatedNCT01485822
A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess the pigmentation in the trabecular meshwork of patients who had been treated for at least 2 years with TRAVATAN compared with patients without exposure (or less than 1 month) to a prostaglandin analogue (PGA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Trabecular Meshwork Tissue Collection | A minimum of two punches were used to remove tissue to form a sclerostomy. Tissue removed by the punch was collected for analysis. Alternatively, the tissue was collected by block excision of the meshwork with scissors at the time of sclerostomy. |
| DRUG | Travoprost 0.004% ophthalmic solution |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2011-12-06
- Last updated
- 2013-05-14
Source: ClinicalTrials.gov record NCT01485822. Inclusion in this directory is not an endorsement.